Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation
Shivani Kapoor(University of Maryland, Baltimore), Maria R. Baer(University of Maryland, Baltimore), Danilo Perrotti(Cancer Genetics (United States)), Manfred Kraus(Harvard University), Karthika Natarajan(Center for Drug Evaluation and Research), Dennis Huszar(Millennium Engineering and Integration (United States)), Trevor J. Mathias(University of Maryland, Baltimore), Rossana Trotta(University of Maryland, Baltimore), Eduardo Dávila(New Mexico State University), Rena G. Lapidus(University of Maryland, Baltimore), Kshama A. Doshi(U-M Rogel Cancer Center), Patrick R. Baldwin(University of Maryland, Baltimore), Mario Scarpa(University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center), Adriana E. Tron
Cited by 51
Related Papers
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795